Moving forward..Onc ready to do something I agree with many of the comments.
One does need to be clarified.
The ATM was announced many times. Over the years & is a subsection if a $150 million! Shelf proscectus.
Regarding the shelf prospectus. Exactky what it says.
Onc has approval to at anytime issue up to, including the $$ to date, $150million in shares.
No further notice required. They do & have updated that document, I believe on an annual basis.
As a sub- activity of that prospectus, they have announced various ATM deals , over the years.
The ATM " deal" allows Onc to sell to that agency. At market price. 100% at Onc discretion.
The agency as part of that agreement can not at anytime short the shares.
Over the years, there have been 4-5 different ATM arrangements, with different companies.
i can't recall who the existing one is, but not Cannacord.
So, they absolutely could at any time invoke the ATM, withiut notice. As the notice was given at time of the agreement.
now..limoortanly, I don't think the ATM was large enough to support , what we saw Wed.
possibky some if the 32 million shares, certainly not all.
regarding Bucky. Obviously a " not well " individual.
I put him on ignore as my NY resolution. Much nicer not having to resd his grade 4 level nonsense.
i also sent him an inbox message, he is too much of a coward to reply.
Big picture with ONC ?
My business contact, at one time was a portfolio manager for Blackrock in USA.
if you don't know about blackrock , look it up.
this person, is a trusted friend of mine.
I asked for some look around, regarding onc(y).
seems there is an information wall right now.
All that was obtained was the printed public Analysts report. Yes using expectations of Pela getting to market. Using Net present value calculations of the expected future income, with a huge discount for time risk,.l.a buy recommendation of $6ps , with an $18ps upside if / when a partner is announced.
Yes , all speculation based on industry standards of evaluation.
explaining the reasons behind the numbers.
The info is so tight. My contact would not send report over email, but did offer to snail mail from out of office.
Cloak & dagger stuff, nit sure. Could just be the legal limitations this person is bound by.
regarding the recent trading way over the top of 32 million.
i asked.
answer ": something is up"...in that persons opinion.
I think we can all agree, Wed trading was way beyond normal.
Tuesday, they will reveal the efficacy results of the Annal cohort with Roche.
Anything is possible. One thing about Onc , they have always surprised.
Worst was when PanCan announced they were haulting ALL trials going forward, due to funding issues.
That was terrible for ONC.
They survived & still recieved the $5 million grant for the recently announced & progressing cohort with florfinox , aka cohort # 5 within the Roche Gobblet sequence of trials.
Sadly & irinically , I'm waiting on a phone call from a very close friend of mine.
He is suspected to have panc cancer.
I pray not. Let's hope Pelareorep crosses the magic line & gets approved.
BTW, safety with Panc cancer chemo etc, very important.
Pela has next to zero side effects. Not to be said about many of the inplace standard uf care meds.